ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:41 am Sale |
2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 531,914 1.980% |
-2,092,070 (-79.73%) |
Filing |
| 2024-02-07 07:09 am Purchase |
2023-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,623,984 9.990% |
1,370,156 (+109.28%) |
Filing |
| 2023-01-25 5:00 pm Purchase |
2023-01-15 | 13G | Syros Pharmaceuticals, Inc. SYRS |
ADAGE CAPITAL PARTNERS GP LLC | 1,253,828 6.040% |
1,253,828 (New Position) |
Filing |